Transplant long-surviving induced by CD40-CD40 ligand costimulation blockade is dependent on IFN-γ through its effect on CD4+CD25+ regulatory T cells

Transplant Immunology

Volumn 24, Issue 2, 2011, Pages 113-118

  Jiang, Xiao Feng ^a   Zhu, Lei ^a   Cui, Zhe Ming ^a   Guo, Da Wei ^a   Sun, Wen Yu ^a   Lin, Lin ^a   Tang, Yu fu ^a   Wang, Xue fan ^a   Liang, Jian ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

CD40 CD40L costimulation; CD4+CD25+ regulatory T cells; Heart transplantation; IFN ; Transplant long surviving

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 4; TRANSCRIPTION FACTOR FOXP3;

ACUTE GRAFT REJECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GRAFT SURVIVAL; HEART TRANSPLANTATION; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; SPLEEN TRANSPLANTATION; SURVIVAL TIME; UPREGULATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD40; CD40 LIGAND; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE CULTURE TEST, MIXED; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 78650307252     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2010.10.005     Document Type: Article

References (40)

1. Golshayan D., Buhler L., Lechler R.I., Pascual M. From current immunosuppressive strategies to clinical tolerance of allografts. Transpl Int 2007, 20:12-24.
2. Vincenti F. Costimulation blockade in autoimmunity and transplantation. J Allergy Clin Immunol 2008, 121:299-306.
3. Lechler R.I., Garden O.A., Turka L.A. The complementary roles of deletion and regulation in transplantation tolerance. Nat Rev Immunol 2003, 3:147-158.
4. Platanias L.C. Mechanisms of type-I- and type-II interferon-mediated signalling. Nat Rev Immunol 2005, 5:375-386.
5. Famulski K.S., Einecke G., Reeve J., Ramassar V., Allanach K., Mueller T., et al. Changes in the transcriptome in allograft rejection: IFN-γamma-induced transcripts in mouse kidney allografts. Am J Transplant 2006, 6:1342-1354.
6. Donckier V., Craciun L., Lucidi V., Buggenhout A., Troisi R., Rogiers X., et al. Acute liver transplant rejection upon immunosuppression withdrawal in a tolerance induction trial: potential role of IFN-γamma-secreting CD8+ T cells. Transplantation 2009, 87:S91-S95.
7. Gras J., Wieërs G., Vaerman J.L., Truong D.Q., Sokal E., Otte J.B., et al. Early immunological monitoring after pediatric liver transplantation: cytokine immune deviation and graft acceptance in 40 recipients. Liver Transpl 2007, 13:426-433.
8. Hoerbelt R., Benjamin L.C., Shoji T., Johnston D.R., Muniappan A., Guenther D.A., et al. Effects of tolerance induction on the actions of interferon-gamma on porcine cardiac allografts. Transplant Proc 2006, 38:3196-3198.
9. Rottman M., Soudais C., Vogt G., Renia L., Emile J.F., Decaluwe H., et al. IFN-γamma mediates the rejection of haematopoietic stem cells in IFN-γammaR1-deficient hosts. PLoS Med 2008, 5:152-163.
10. Daniel V., Naujokat C., Sadeghi M., Renner F.C., Weimer R., Opelz G. Association of high IFN-γamma plasma levels with low B-cell counts in renal transplant recipients with stable long-term graft function. Clin Transplant 2010, 24:281-289.
11. Plain K.M., Boyd R., Verma N.D., Robinson C.M., Tran G.T., Hodgkinson S.J., et al. Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administration. Transplantation 2007, 83:764-773.
12. Guillonneau C., Hill M., Hubert F.X., Chiffoleau E., Hervé C., Li X.L., et al. CD40Ig treatment results in allograft acceptance mediated by CD8+CD45Rclow T cells, IFN-γ, and indoleamine 2, 3-dioxygenase. J Clin Invest 2007, 117:1096-1106.
13. Kishimoto K., Sandner S., Imitola J., Sho M., Li Y., Langmuir P.B., et al. Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance. J Clin Invest 2002, 109:1471-1479.
14. Sawitzki B., Kingsley C.I., Oliveira V., Karim M., Herber M., Wood K.J. IFN-γamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J Exp Med 2005, 201:1925-1935.
15. Yang H.R., Chou H.S., Gu X., Wang L., Brown K.E., Fung J.J., et al. Mechanistic insights into immunomodulation by hepatic stellate cells in mice: a critical role of interferon-gamma signaling. Hepatology 2009, 50:1981-1991.
16. Wei B., Baker S., Wieckiewicz J., Wood K.J. IFN-γamma triggered STAT1-PKB/AKT signalling pathway influences the function of alloantigen reactive regulatory T cells. Am J Transplant 2010, 10:69-80.
17. Corry R.J., Winn H.J., Russell P.S. Primary vascularized allografts of hearts in mice: the role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973, 16:343-350.
18. Chen N., Gao Q., Field E.H. Prevention of Th1 responses is critical for tolerance. Transplantation 1996, 61:1076-1083.
19. Wang Z., Hong J., Sun W., Xu G., Li N., Chen X., et al. Role of IFN-γ in induction of Foxp3 and conversion of CD4+CD25- T cells to CD4+ Tregs. J Clin Invest 2006, 116:2434-2441.
20. Bishop D.K., Wood S.C., Eichwald E.J., Orosz C.G. Immunobiology of allograft rejection in the absence of IFN-γ: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions. J Immunol 2001, 166:3248-3255.
21. Berner V., Liu H., Zhou Q., Alderson K.L., Sun K., Weiss J.M., et al. IFN-γamma mediates CD4+ T-cell loss and impairs secondary antitumor responses after successful initial immunotherapy. Nat Med 2007, 13:354-360.
22. Asavaroengchai W., Wang H., Wang S., Wang L., Bronson R., Sykes M., et al. An essential role for IFN-γ in regulation of alloreactive CD8 T cells following allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2007, 13:46-55.
23. Bestard O., Cruzado J.M., Mestre M., Caldés A., Bas J., Carrera M., et al. Achieving donor-specific hyporesponsiveness is associated with FOXP3+ regulatory T cell recruitment in human renal allograft infiltrates. J Immunol 2007, 179:4901-4909.
24. Gavin M.A., Rasmussen J.P., Fontenot J.D., Vasta V., Manganiello V.C., Beavo J.A., et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 2007, 445:771-775.
25. Tellides G., Pober J.S. Interferon-gamma axis in graft arteriosclerosis. Circ Res 2007, 100:622-632.
26. Schoenborn J.R., Wilson C.B. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 2007, 96:41-101.
27. Jiang X., Kojo S., Harada M., Ohkohchib N., Taniguchia M., Seino K. Mechanism of NKT cell-mediated transplant tolerance. Am J Transplant 2007, 7:1482-1490.
28. Halloran P.F. Role of IFN-γamma in allograft rejection. Crit Rev Immunol 2002, 22:317-349.
29. Mitchell R.N., Lichtman A.H. The link between IFN-γamma and allograft arteriopathy: is the answer NO?. J Clin Invest 2004, 114:846-856.
30. Hart-Matyas M., Nejat S., Jordan J.L., Hirsch G.M., Lee T.D. IFN-γamma and Fas/FasL pathways cooperate to induce medial cell loss and neointimal lesion formation in allograft vasculopathy. Transpl Immunol 2010, 22:157-164.
31. Coley S.M., Ford M.L., Hanna S.C., Wagener M.E., Kirk A.D., Larsen C.P. IFN-γamma dictates allograft fate via opposing effects on the graft and on recipient CD8 T cell responses. J Immunol 2009, 182:225-233.
32. Zhang J. Yin and yang interplay of IFN-γamma in inflammation and autoimmune disease. J Clin Invest 2007, 117:871-873.
33. Kelchtermans H., De Klerck B., Mitera T., Van Balen M., Bullens D., Billiau A., et al. Defective CD4+CD25+ regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-γ. Arthritis Res Ther 2005, 7:R402-R415.
34. Yu X.Z., Albert M.H., Martin P.J., Anasetti C. CD28 ligation induces transplantation tolerance by IFN-γamma-dependent depletion of T cells that recognize alloantigens. J Clin Invest 2004, 113:1624-1630.
35. Wang H., Asavaroengchai W., Yeap B.Y., Wang M.G., Wang S., Sykes M., et al. Paradoxical effects of IFN-γamma in graft-versus-host disease reflect promotion of lymphohematopoietic graft-versus-host reactions and inhibition of epithelial tissue injury. Blood 2009, 113:3612-3619.
36. Welniak L.A., Blazar B.R., Murphy W.J. Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu Rev Immunol 2007, 25:139-170.
37. Sis B., Famulski K.S., Allanach K.L., Zhu L.F., Halloran P.F. IFN-γ Prevents Early Perforin-Granzyme-Mediated Destruction of Kidney Allografts by Inducing Donor Class I Products in the Kidney. Am J Transplant 2007, 7:2301-2310.
38. Wood K.J., Feng G., Wei B., Sawitzki B., Bushell A.R. Interferon gamma: friend or foe?. Transplantation 2007, 84:S4-S5.
39. Fairchild R.L. The Yin and Yang of IFN-γ in allograft rejection. Am J Transplant 2003, 3:913-914.
40. Nicolls M.R., Coulombe M., Yang H., Bolwerk A., Gill R.G. Anti-LFA-1 therapy induces long-term islet allograft acceptance in the absence of IFN-γ or IL-4. J Immunol 2000, 164:3627-3634.